(Q51064463)

28 March 2018

title

Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations. (English)

1 reference

28 March 2018

author name string

Shengjuan Shao

1

1 reference

28 March 2018

Rilei Yu

2

1 reference

28 March 2018

Yanqing Yu

3

1 reference

28 March 2018

Yanni Li

4

1 reference

28 March 2018

publication date

7 August 2014

1 reference

28 March 2018

Journal of Molecular Modeling

published in

1 reference

28 March 2018

volume

20

1 reference

28 March 2018

issue

8

1 reference

28 March 2018

page(s)

2399

1 reference

28 March 2018

https://scigraph.springernature.com/pub.10.1007/s00894-014-2399-x

exact match

0 references

cites work

BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Treatment of chronic myeloid leukemia following imatinib resistance: a nursing guide to second-line treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Shooting the messenger: targeting signal transduction pathways in leukemia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Managing resistance in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Signal transducer and activator of transcription proteins in leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

STAT3 as a therapeutic target in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Structural basis for the binding of high affinity phosphopeptides to Stat3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Stattic: a small-molecule inhibitor of STAT3 activation and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Design, synthesis, and studies of small molecule STAT3 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Discovery of chromone-based inhibitors of the transcription factor STAT5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Three-dimensional structure of the Stat3beta homodimer bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Structure of the unphosphorylated STAT5a dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

The Amber biomolecular simulation programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Development and testing of a general amber force field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2/MDMX interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Antagonism of the Stat3-Stat3 protein dimer with salicylic acid based small molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

HIV-1 protease inhibitors: enthalpic versus entropic optimization of the binding affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Structural parameterization of the binding enthalpy of small ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Direct measurement of protein binding energetics by isothermal titration calorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-014-2399-X

Validating Stat3 in cancer therapy

21 January 2018

1 reference

12 December 2020

Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations

1 reference

12 December 2020

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance.

1 reference

12 December 2020

Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.

1 reference

12 December 2020

Molecular dynamics and free energy studies on Aurora kinase A and its mutant bound with MLN8054: insight into molecular mechanism of subtype selectivity

1 reference

12 December 2020

WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).

1 reference

12 December 2020

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

12 December 2020

10.1007/S00894-014-2399-X

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018